Yendt E R, Cohanim M
Clin Invest Med. 1986;9(1):44-50.
This report describes studies performed over an 11 year period in a 13 year old girl with hyperoxaluria and calcium oxalate nephrolithiasis who did not have primary hyperoxaluria or any of the recognized causes of secondary hyperoxaluria. The patient also had increased urinary excretion of calcium and magnesium and hyperabsorption of dietary calcium and magnesium. It is suggested that the hyperoxaluria resulted from hyperabsorption of dietary oxalate secondary to hyperabsorption of dietary calcium. Hyperabsorption of dietary magnesium and increased urinary magnesium excretion have not previously been reported in this context. Stone formation ceased and urinary oxalate excretion gradually fell to normal during long term thiazide therapy but hyperoxaluria recurred when orthophosphate therapy was substituted for the hydrochlorothiazide. This is the first report of normalization of urine oxalate excretion during thiazide therapy in a patient with frank hyperoxaluria.
本报告描述了对一名13岁患有高草酸尿症和草酸钙肾结石的女孩进行的为期11年的研究,该女孩没有原发性高草酸尿症或任何已确认的继发性高草酸尿症病因。该患者还存在尿钙和尿镁排泄增加以及膳食钙和镁的高吸收情况。有人认为,高草酸尿症是由于膳食钙的高吸收继发膳食草酸盐的高吸收所致。膳食镁的高吸收和尿镁排泄增加在此情况下此前尚未见报道。在长期噻嗪类药物治疗期间,结石形成停止,尿草酸盐排泄逐渐降至正常,但当用正磷酸盐治疗替代氢氯噻嗪时,高草酸尿症复发。这是首次报道在患有明显高草酸尿症的患者中噻嗪类药物治疗期间尿草酸盐排泄恢复正常的情况。